Higher Interrater Agreement of FDG-PET/CT than Bone Scintigraphy in Diagnosing Bone Recurrent Breast Cancer

by Jorun Holm, Ziba Ahangarani Farahani, Oke Gerke, Christina Baun, Kirsten Falch, Malene Grubbe Hildebrandt
Published 2020-11-01

Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer

by Jonas S. Sørensen, Mie H. Vilstrup, Jorun Holm, Marianne Vogsen, Jakob L. Bülow, Lasse Ljungstrøm, Poul-Erik Braad, Oke Gerke, Malene G. Hildebrandt
Published 2020-11-01

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond

by Malene Grubbe Hildebrandt, Jeppe Faurholdt Lauridsen, Marianne Vogsen, Jorun Holm, Mie Holm Vilstrup, Poul-Erik Braad, Oke Gerke, Mads Thomassen, Marianne Ewertz, Poul Flemming Høilund-Carlsen, The Centre for Personalized Response Monitoring in Oncology (PREMIO)
Published 2019-08-01